ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis

This study has been completed.
Study NCT00035334.   Last updated on February 13, 2006.   Information provided by Bellus Health Inc
Please refer to this study by its ClinicalTrials.gov identifier: NCT00035334


Locations
United States, Indiana
Indiana University School of Medicine, Department of Pathology and Laboratory Medicine,    
      Indianapolis, Indiana, United States, 46202
United States, Massachusetts
Boston Medical Center, Renal Division    
      Boston, Massachusetts, United States, 02118
United States, Minnesota
Mayo Clinic    
      Rochester, Minnesota, United States, 55905
United States, New York
Mount Sinai Medical Center    
      New York, New York, United States, 10029
Finland
Rheumatism Foundation Hospital    
      Heinola, Finland, FIN-18120
France
Hôpital Claude Huriez, Service de médecine Interne, Clinique Médicale A    
      Lille, France, CEDEX 59037
Centre Hospitalier du Mans, Service de Rhumatologie    
      Le Mans, France, CEDEX 1
Hôpital Cochin, Centre de Recherche et d'Explorations Fonctionnelles    
      Paris, France, 75679 CEDEX 14
Israel
Bnai Zion Medical Center    
      Haifa, Israel, 31048
Heller Institute of Medical Research, Sheba Medical Center    
      Tel Hashomer, Israel, 52621
Italy
Italian Group for Systemic Amyloidosis, Biotechnology Research Laboratories, IRCCS Policlinico San Matteo, Internal Medicine and Medical Oncology    
      Pavia, Italy, 27100
Lithuania
Vilnius University Hospital    
      Vilnius, Lithuania, 2001
Netherlands
University Hospital Groningen, Department of Medicine, Division of Rheumatology    
      Groningen, Netherlands, 9700 RB
Poland
Instytut Reumatologiczny    
      Warszawa, Poland, 02-632
Okregowy Szpital Kolejowy, Zaklad Reumatologii    
      Wroclaw, Poland, 53-137
Russian Federation
Regional Hospital No. 1    
      Yekaterinburg, Russian Federation, 320102
Institute of Rheumatology RAMS    
      Moscow, Russian Federation, 115522
Spain
Ciutad Sanitària y Universitària de Bellvitge, Servicio de Reumatologia, Hospitalet de Llobregat    
      Llobregat, Spain, 08907
Hospital Universitario Germans Trias I Pujol, Servicio de Reumatologia    
      Badalona, Spain, 08916
Hospital Clinic I Provincial de Barcelona, Jefe del Departamento de Reumatologia    
      Barcelona, Spain, 08036
Hospital Clinico San Carlos de Madrid, Servicio de Reumatologia    
      Madrid, Spain, 28040
Turkey
Istanbul Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology    
      Istanbul, Turkey, 34390 CAPA
Marmara University Medical School Hospital, Department of Rheumatology    
      Uskudar, Altunizade, Istanbul, Turkey, 81190
Cerrehpasa Tip Fakultesi    
      Askaray, Istanbul, Turkey, Turkey
United Kingdom
Gartnavel General Hospital    
      Scotland, United Kingdom, G12 0YN
Royal Free and University College Medical School, Department of Medicine, National Amyloidosis Centre    
      London, United Kingdom, NW3 2PF

Sponsors and Collaborators
Bellus Health Inc
FDA Office of Orphan Products Development





Links to all studies - primarily for crawlers